Axel Bolte - 30 Sep 2022 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Chief Executive Officer, Director
Signature
/s/ Axel Bolte
Issuer symbol
INZY
Transactions as of
30 Sep 2022
Net transactions value
+$7,558
Form type
4
Filing time
04 Oct 2022, 08:00:14 UTC
Previous filing
13 May 2022
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Award $7,558 +3,315 +1.3% $2.28 261,890 30 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2022 through September 30, 2022. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the issuer's common stock on September 30, 2022.